Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
Johnson & Johnson(JNJ) stock is priced at $246.53, giving the company a market capitalization of 594.72B. It carries a P/E multiple of 22.36 and pays a dividend yield of 2.1%.
During the trading session on 2026-03-04, Johnson & Johnson(JNJ) shares reached a daily high of $247.88 and a low of $244.36. At a current price of $246.53, the stock is +0.9% higher than the low and still -0.5% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 6.17M, versus its average volume of 9.26M.
The stock's 52-week range extends from a low of $141.50 to a high of $251.71.
The stock's 52-week range extends from a low of $141.50 to a high of $251.71.
JNJ News
Johnson & Johnson JNJ is one of the key pharmaceutical players in the oncology segment, with its Oncology segment comprising around 27% of total revenues and 42...
Johnson & Johnson (JNJ) is back in focus after releasing preliminary Phase 1b data on pasritamig plus docetaxel in metastatic castration-resistant prostate canc...
Johnson & Johnson announced that nipocalimaba was granted U.S. FDA Fast Track designation as a potential treatment for adults with systemic lupus erythematosus,...
Analyst ratings
57%
of 28 ratingsMore JNJ News
BofA analyst Jason Gerberry raised the firm’s price target on Johnson & Johnson to $253 from $227 and keeps a Neutral rating on the shares. The firm increased i...
In a report released yesterday, Jason Gerberry from Bank of America Securities reiterated a Hold rating on Johnson & Johnson, with a price target of $253.00. J...
JPMorgan Equity Premium Income ETF ( $JEPI ) has risen by 1.23% in the past week. It has experienced a 5-day net inflow of $325.13 million. This is due, in par...
Key Points Middleby built both businesses through acquisitions, and the roll-up strategy is expected to continue. The commercial foodservice segment anchors t...
Insiders have been trading these 5 stocks: ((BA)), ((WMT)), ((KO)), ((F)) and ((JNJ)). Here is a breakdown of their recent trades and their value. EVP and Chie...
A Philadelphia jury found Johnson & Johnson (NYSE:JNJ) liable in a talc ovarian cancer lawsuit. The verdict is the first plaintiff win in Philadelphia’s talc m...
Johnson & Johnson announced preliminary results from a Phase 1b study evaluating pasritamig, a first-in-class bispecific T-cell engaging antibody, in combinatio...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.